BridgeBio Pharma, Inc. SEC filings BBIO
BridgeBio Pharma, Inc. has 833 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 17, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Other events
|
Jul 22, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 26, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Other events
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 13, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 8, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2026 | May 6, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 21, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Other events
|
Oct 27, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 2, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
|
Feb 28, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 20, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Sep 11, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 21, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2024 | Jul 23, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Other events
|
Jun 6, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 6, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 4, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 17, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 4, 2023 | May 3, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 9, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 23, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 6, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Other events
|
Sep 23, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 26, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 18, 2022 | May 12, 2022 |
| 8-K |
Current report
Material agreement
|
May 13, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 27, 2021 | Dec 27, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Dec 16, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Other events
|
Nov 18, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 26, 2021 | Oct 23, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 23, 2021 | Aug 17, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2021 | Jun 17, 2021 |
| 8-K | Current report | Jun 1, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 6, 2021 |
| 8-K |
Current report
Other events
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 15, 2021 | Apr 13, 2021 |
| 8-K |
Current report
Other events
|
Mar 31, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 17, 2021 | Feb 11, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 29, 2021 | Jan 25, 2021 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jan 26, 2021 | Jan 25, 2021 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jan 26, 2021 | Jan 26, 2021 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 20, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Other events
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 4, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 6, 2020 | Nov 6, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2020 | Oct 21, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2020 | Oct 5, 2020 |
| 8-K |
Current report
Other events
|
Oct 5, 2020 | Oct 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2020 | Sep 29, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 24, 2020 | Jun 23, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2020 | Jun 2, 2020 |
| 8-K |
Current report
Results of operations
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 29, 2020 | Apr 27, 2020 |
| 8-K |
Current report
Other events
|
Mar 24, 2020 | Mar 24, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Mar 10, 2020 | Mar 4, 2020 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Mar 6, 2020 | Mar 4, 2020 |
| 8-K |
Current report
Other events
|
Mar 4, 2020 | Mar 4, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2020 | Mar 2, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Material agreement
|
Jan 7, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Dec 26, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 17, 2019 | Dec 12, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 19, 2019 | Nov 13, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 12, 2019 | Sep 9, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 3, 2019 | Jun 26, 2019 |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1743881
- Former names
- BridgeBio Pharma LLC (until May 16, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.